345 related articles for article (PubMed ID: 31585514)
1. Quantification of plasma cell-free DNA levels in dogs with various tumors.
Tagawa M; Shimbo G; Inokuma H; Miyahara K
J Vet Diagn Invest; 2019 Nov; 31(6):836-843. PubMed ID: 31585514
[TBL] [Abstract][Full Text] [Related]
2. Plasma cell-free DNA in canine lymphoma patients as a novel material for genotyping.
Kambayashi S; Ono N; Tone T; Baba K; Okuda M
Vet Comp Oncol; 2024 Jun; 22(2):303-309. PubMed ID: 38287199
[TBL] [Abstract][Full Text] [Related]
3. Comparison of circulating DNA in malignant neoplasia from diverse locations: Investigating a diagnostic role.
Kumari S; Mishra S; Husain N; Verma T; Tiwari V; Kaif M; Agarwal A; Rastogi M; Shukla S; Sonkar AA
Indian J Pathol Microbiol; 2022; 65(1):93-99. PubMed ID: 35074971
[TBL] [Abstract][Full Text] [Related]
4. Clinical utility of liquid biopsy in canine oral malignant melanoma using cell-free DNA.
Tagawa M; Aoki M
Front Vet Sci; 2023; 10():1182093. PubMed ID: 37408834
[TBL] [Abstract][Full Text] [Related]
5. Circulating Cell-Free DNA in Dogs with Mammary Tumors: Short and Long Fragments and Integrity Index.
Beffagna G; Sammarco A; Bedin C; Romualdi C; Mainenti M; Mollo A; Cavicchioli L; Ferro S; Trez D; De Maria R; Nitti D; Saccani A; Campanella M; Agostini M; Zappulli V
PLoS One; 2017; 12(1):e0169454. PubMed ID: 28081183
[TBL] [Abstract][Full Text] [Related]
6. Circulating cell-free DNA in plasma of colorectal cancer patients - A potential biomarker for tumor burden.
Bhangu JS; Taghizadeh H; Braunschmid T; Bachleitner-Hofmann T; Mannhalter C
Surg Oncol; 2017 Dec; 26(4):395-401. PubMed ID: 29113658
[TBL] [Abstract][Full Text] [Related]
7. Determining prognosis in canine sepsis by bedside measurement of cell-free DNA and nucleosomes.
Letendre JA; Goggs R
J Vet Emerg Crit Care (San Antonio); 2018 Nov; 28(6):503-511. PubMed ID: 30299568
[TBL] [Abstract][Full Text] [Related]
8. Cell-Free DNA Integrity: Applications.
Ravaioli S
Methods Mol Biol; 2019; 1909():77-83. PubMed ID: 30580423
[TBL] [Abstract][Full Text] [Related]
9. Circulating cell-free DNA variables as marker of ovarian cancer patients: A pilot study.
Stamenkovic S; Cheng J; Surowy H; Burwinkel B; Gündert M
Cancer Biomark; 2020; 28(2):159-167. PubMed ID: 32176629
[TBL] [Abstract][Full Text] [Related]
10. Alter circulating cell-free DNA variables in plasma of ovarian cancer patients.
Yu Z; Qin S; Wang H
J Obstet Gynaecol Res; 2019 Nov; 45(11):2237-2242. PubMed ID: 31502389
[TBL] [Abstract][Full Text] [Related]
11. Relationship between plasma cell-free DNA changes and lysyl oxidase during the treatment and prognosis of canine transmissible venereal tumors.
Mohamadzaheri M; Cheraghi H; Shirani D; Hatamkhani A
BMC Vet Res; 2022 Feb; 18(1):76. PubMed ID: 35189882
[TBL] [Abstract][Full Text] [Related]
12. Measurement of plasma cell-free DNA concentrations in dogs with sepsis, trauma, and neoplasia.
Letendre JA; Goggs R
J Vet Emerg Crit Care (San Antonio); 2017 May; 27(3):307-314. PubMed ID: 28295988
[TBL] [Abstract][Full Text] [Related]
13. Quantitative analysis of the BRAF V595E mutation in plasma cell-free DNA from dogs with urothelial carcinoma.
Tagawa M; Tambo N; Maezawa M; Tomihari M; Watanabe KI; Inokuma H; Miyahara K
PLoS One; 2020; 15(4):e0232365. PubMed ID: 32330187
[TBL] [Abstract][Full Text] [Related]
14. Increased Plasma Circulating Cell-Free DNA Could Be a Potential Marker for Oral Cancer.
Lin LH; Chang KW; Kao SY; Cheng HW; Liu CJ
Int J Mol Sci; 2018 Oct; 19(11):. PubMed ID: 30352977
[TBL] [Abstract][Full Text] [Related]
15. Plasma cell-free DNA level and its integrity as biomarkers to distinguish non-small cell lung cancer from tuberculosis.
Leng S; Zheng J; Jin Y; Zhang H; Zhu Y; Wu J; Xu Y; Zhang P
Clin Chim Acta; 2018 Feb; 477():160-165. PubMed ID: 29113814
[TBL] [Abstract][Full Text] [Related]
16. Circulating free DNA integrity and concentration as independent prognostic markers in metastatic breast cancer.
Cheng J; Holland-Letz T; Wallwiener M; Surowy H; Cuk K; Schott S; Trumpp A; Pantel K; Sohn C; Schneeweiss A; Burwinkel B
Breast Cancer Res Treat; 2018 May; 169(1):69-82. PubMed ID: 29340881
[TBL] [Abstract][Full Text] [Related]
17. Plasma ALU-247, ALU-115, and cfDNA Integrity as Diagnostic and Prognostic Biomarkers for Breast Cancer.
Hussein NA; Mohamed SN; Ahmed MA
Appl Biochem Biotechnol; 2019 Mar; 187(3):1028-1045. PubMed ID: 30151636
[TBL] [Abstract][Full Text] [Related]
18. Plasma Cell-Free DNA as a Predictive Marker after Radiotherapy for Hepatocellular Carcinoma.
Park S; Lee EJ; Rim CH; Seong J
Yonsei Med J; 2018 Jun; 59(4):470-479. PubMed ID: 29749129
[TBL] [Abstract][Full Text] [Related]
19. Age-stratified reference intervals unlock the clinical potential of circulating cell-free DNA as a biomarker of poor outcome for healthy individuals and patients with colorectal cancer.
Ørntoft MW; Jensen SØ; Øgaard N; Henriksen TV; Ferm L; Christensen IJ; Reinert T; Larsen OH; Nielsen HJ; Andersen CL
Int J Cancer; 2021 Apr; 148(7):1665-1675. PubMed ID: 33320961
[TBL] [Abstract][Full Text] [Related]
20. Quantification of circulating plasma cell free DNA fragments in patients with oral cancer and precancer.
Desai A; Kallianpur S; Mani A; Tijare MS; Khan S; Jain M; Mathur V; Ahuja R; Saxena V
Gulf J Oncolog; 2018 May; 1(27):11-17. PubMed ID: 30145546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
